CHARLOTTE, N.C.--(BUSINESS WIRE)--IperionX Limited (NASDAQ: IPX, ASX: IPX) (IperionX or Company) is pleased to announce the positive results of the Scoping Study (Scoping Study or Study) on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results